VCRE
Vicore Pharma Holding AB
9.40$
-0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | 100.0% | 100.0% | |
| – | – | 100.0% | 100.0% | |
| – | – | 228.0% | 10,226.6% | |
| – | – | 46.1% | 1,779.3% | |
| – | – | 274.1% | 12,005.8% | |
| – | – | -174.1% | -11,905.8% | |
| – | – | 0.0% | 1.6% | |
| – | – | -154.5% | -12,509.1% | |
| – | – | -154.2% | -12,509.1% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.